chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient's mother brought patient in to receive a COVID-19 Pfizer vaccine on 08/28/2021.  The patient?s mother filled out a consent form on behalf of the patient and listed the date of birth as 07/22/2009 and signed and consented on the local Health Department Pfizer-BioNTech consent form.  The nurse verified the name and date of birth with the patient and the patient?s mother.  Local Public Health guidelines were followed, and the parent received the up-to-date Pfizer-BioNTech EUA and the vaccine was administered.  In the patient?s 15-minute wait there were no adverse reactions. Three weeks later, on 09/18/2021 the mother once again filled out a consent form and stated her child's birthday was 07/22/2009.Once again, the nurse verified the date of birth with both the patient and the mother and the up-to-date EUA was given to the patient's parent and the vaccine was administered.  Upon entering the vaccine into the database it was discovered that the patient's true DOB was 07/22/2010  and therefore this was an unauthorized vaccination.  The date of birth was then confirmed and verified in the National database.  The local Health Department Chief Medical Director was notified.  In addition, the patient's mother and pediatrician were notified per protocol.
Approximately 24 hours after recieving the vaccine the back of my arm swelled from my elbow to my deltoid and to both sides of my arm. The area was itchy, red and tender.
Developed a rash a few days after the injection.  This was not treated and now (eight days after treatment is quickly fading and nearly gone.
fever; chills; fatigue; This is a spontaneous report from a non-contactable consumer (patient) or other non hcp. A 46-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EW0185, Expiration Date: was not reported), via an unspecified route of administration, administered in right arm, on 14Jun2021 at 08:00 (at the age of 46 year), as dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included Vitamin-D taken for an unspecified indication, start and stop date were not reported; Zinc taken for an unspecified indication, start and stop date were not reported; Probiotics taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EW0167, Expiration Date: was not reported), via an unspecified route of administration, administered in right arm, on 22May2021 at 13:30 (at the age of 46 year), as dose 1, single for COVID-19 immunization and the patient experienced extreme soreness in right arm (shoulder area) immediately after first shot which lasted for about four days. The patient was not pregnant. The patient was not received other vaccine in four weeks. The patient received other medication in two weeks were Vitamin D, Zinc, Probiotics. The adverse event was not resulted in emergency room or physician office visit. Prior to vaccination, the patient was not infected to COVID-19. Post vaccination, the patient was not tested for COVID-19. The patient had no known allergies. On 14Jun2021 at 20:00 (12 hours after getting the second vaccine dose), the patient experienced fever, chills, and fatigue kicked in and lasted for about 48 hours. The patient was not received treatment for the adverse events. The outcome of fever, chills, fatigue was recovered on 16-JUN-2021 at 20:00.  No Follow-up attempts are possible. No further information is expected.
About 5 days after my vaccine, began ringing sensation in my right ear and it has been there ever since. They did an audiology test and also an MRI to rule out tumor and it was normal.  As today I still have the ringing sensation to my right ear.
she couldn't put in any exercise up and down/ cannot hold her hand up and it got fall in; she couldn't feel any muscle. It is stiff; Left shoulder that is at the site I got the vaccine in pain.; Left shoulder that is at the site I got the vaccine in pain.; I have pain in muscle; I can not hold my hand up and it got fall in.; This is a spontaneous report received from a contactable consumer (patient) and a contactable other health professional. An 84-year-old female patient received second dose of bnt162b2 (Batch/Lot Number: ER8727), via an unspecified route of administration in left arm on 31Mar2021 as single dose for covid-19 immunization. Medical history included high blood pressure and high cholesterol from an unknown date and unknown if ongoing. Concomitant medications included ongoing amlodipine besilate (NORVASC) taken for hypertension; ongoing rosuvastatin taken for high cholesterol. The patient previous took the first dose of bnt162b2 on 10Mar2021 for covid-19 immunization. On 31Mar2021, she had pain in muscle, and she cannot hold her hand up and it got fall in. The muscle pain was so much. She cannot her hand up, she was in so much pain. Left shoulder that was at the site she got the vaccine in pain. She took 1st shot of covid vaccine on 10Mar2021. It is 31Mar2021 for second shot. Lab test: just blood test. She took for her heart and for lymph node. It was Biopsy. It was two weeks ago. She didn't remember the date. She took a nuclear test for her heart. Everything was negative. She got the vaccine in her arm and it wasn't that bad you know until I don't know. In morning she woke up and after the exercise pain in muscle and she couldn't feel any muscle. It is stiff, she couldn't put in any exercise up and down, her muscles she wanted to know what to do with it. She took paracetamol (TYLENOL) in this morning. The patient underwent lab tests and procedures which included biopsy: negative, nuclear test for heart: negative both on an unspecified date. The outcome of events for pain in muscle, Left shoulder that was at the site she got the vaccine in pain were not resolved, for other events was unknown.  No follow-up attempts are needed. No further information is expected.
No adverse drug reaction or adverse patient effect. Administered one day past manufacturer expiration. Per Moderna Case ID, vaccine maintained activity at time administered.
painful rash on his upper back that spread around left side and was diagnosed with acute herpes zoster neuropathy; painful rash on his upper back that spread around left side and was diagnosed with acute herpes zoster neuropathy; Information has been received from a lawyer regarding a case in litigation and refers to a male patient (pt.) of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.  On or about 28-MAY-2017, the pt. was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route of administration was not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) by an unknown health care provider (HCP).  On an unspecified date (reported as shortly after receiving zoster vaccine live (ZOSTAVAX) vaccine), the pt. experienced a painful rash on his upper back that spread around left side and was diagnosed with acute herpes zoster neuropathy.  As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, the pt. had resulted in physical limitations not presented prior to the use of the vaccine. Pt. also experienced mental and emotional distress due to resulting in physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt. sustained severe and permanent personal injuries. The pt. suffered serious, progressive, permanent and incurable injuries as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life; physical impairment and injury; and other damages including medical expenses, the loss of accumulations, and other economic and non-economic damages.  At the reporting time, he was not recovered of acute herpes zoster neuropathy.  The reporter considered the event of acute herpes zoster neuropathy to be related to zoster vaccine live (ZOSTAVAX). The reporter considered the acute herpes zoster neuropathy to be disabling.
11/24/22 I felt okay in the morning. As the day went on, I became tired and lost my voice. I started getting congested. On 11/25/22 I had to move to the recliner to sleep because I was so stuffy. I took a home COVID test and it was positive. I contacted my doctor, and she suggested not to take PAXLOVID at that time. I did not get the PAXLOVID. The stuffy nose lasted about 5 days. The fatigue lasted around ten days. Then I was just tired for about another week. I saw my doctor on telehealth 12/16/22 and I had no issues she was worried about. I have recovered.
Patient came for WCV 8/23/07 AM - had immunizations, on 8/28/07 - Mother called to report (L) leg with redness and swelling was treated by on call MD. Patient came for f/u visit 8/27/07 - sxs improving.
tiredness, headache, severe muscle pain , chills, severe joint pain nausea, feeling unwell
About 12 hrs after injection - onset of anxiety, agitation, unsteadiness - loss of balance with fall. Chills - 24 hrs after injection.
Sore arm as expected. Fatigue (still in effect, ) Severe headache ( helped/resolved by Tylenol). Some queasiness/dizziness
Felt abnormal and went to bed. Woke up at 9:35am with 101.7 temperature and called into work to advise I will not be coming in.  I went back to bed no food no medicine,  Most information I read and was aware is that it would be better with sleep.   Only to wake up at 8:30pm with a 102.7 had 500 mg acetaminophen went back to bed.   Woke up Thursday morning at 9:45am fever free.    Friday afternoon  I noticed swelling on my left neck area.  Just inside my left clavicle.  I made a Dr appointment for Monday and Dr. found several Lymph nodes swollen as well as under my left arm pit area.   Due to some chest pain she sent me for a chest x-ray.
Patient reports that she developed right sided tongue tingling after 35-45 minutes of receiving the vaccine. Went home and took Tylenol. Woke up the next day with right sided tongue feels swollen with tingling and numbness that radiates to right ear. She will be evaluated in Occupational Health today.
Rashes and unexplained bruises because apparent Nov 30, 2021. COVID booster was given on 12/20/2021. Started having abdominal pain January 2022. March 2, 2022 diagnosed with rare Anaplastic T Cell Non Hodgkins Lymphoma ALK type negative
Approximately 3-5 minutes after vaccination, patient reports walked towards post-vaccination area and vision began closing in to where she could not see.  Accoriding to post vaccination staff witness, patient appeard to walk into traffic cone and then stumbled and fell to knees on asphalt. Staff assisted patient to lying position. Patient did not hit head. Patient alert and oriented x3, and remained so for the duration. BP taken at scene at 1326  (124/80 HR 90 R 18); 1329 (120/78 HR 78 R 18); 1335-standing (120/82 HR 80 R 18); 1346 sitting(122/72 HR 80 R 18). Allowed patient to lie down until she reported feeling better. Vital signs also taken in sitting and standing position--all stable, reports no dizziness.
Grandmother called and spoke with RN in clinic on 2/18/09 informing her patient had seizure on morning of 2/18/09, and wanted Dr informed. Phone message transfered to Dr by RN who took call. Grandmother also spoke with receptionist from clinic same morning who transferred her call to Pediatric Neurologist's office. Seizure not witnessed by medical personel. Child has been referred in past to peds neurology, genetics, nephrology, cardiology, dietician, opthamologist, nuerology, home health nurse.
Patient said she was feeling well and she received her flu shot and Shingrix second dose on September 17.  She noted her arm felt a bit sore later that day but the next day started and with a constant, "horrible ache".  She said it moves up into her posterior neck.  She has been taking some ibuprofen and increasing the dose to 600 mg did seem to help and she slept overnight.  She also has been experiencing a bit of a normal headache and has taken a Fioricet in the last 24 hours.  She has decreased range of motion that she is noted over the last few days and can only abduct the arm to about 45 degrees.  She is able to lift it with her other arm but cannot elevate it on her own.  She denies any numbness or other weakness and arm.  Her grip strength she says is normal.  She denies any trauma.  She otherwise feels well and denies any fever.  She denies any redness or swelling at the site of injection
pt recvd vax;axillary adenopathy tx w/ moist heat compress;13jan95 f/u: complete recovery
tested positive for Corona Virus/ symptomatic and has been sick; tested positive for Corona Virus/ symptomatic and has been sick; This is a spontaneous report from a Pfizer-sponsored program by a contactable other HCP reported for self. This 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an 18Dec2020 10:45 am on left arm at single dose (Lot # EK5730) for routine vaccination. No additional vaccines received on the same date. Vaccination facility type was hospital. None medical history, concomitant medications or past drug history. She has a patient on the line who got the COVID vaccine on Friday (18Dec2020 10:45), and on Sunday (20Dec2020) she tested positive for the Corona Virus. The main reason she called is to figure out what to do about the booster. There is not really enough data to determine this at this point. There was no prescriber.  She just received it at the hospital.  She is symptomatic and has been sick on 18Dec2020 all weekend.  Saturday (19Dec2020) is when she began to have more significant symptoms and on Sunday (20Dec2020) as well.  Today, she is better, but still symptomatic. She became symptomatic on Friday night 18Dec2020, and experienced loss of smell, extreme fatigue, mild cough, nasal congestion.  She states all were related to COVID.  This all started around 7:30 pm. Relevant test included Positive for Corona Virus on Sunday, 20Dec2020. Relevant test included Positive for COVID test (Corona Virus) on Sunday, 20Dec2020. Outcome of the events was unknown.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient might not be completely excluded.
Rash developed on trunk on 9/4/06, spread to rest of body and face by 95/06.  Reports no fever or other symptoms.  Took to Dr. at a walk in clinic who said it could be vaccination.
- Restless legs, Feeling like an electrical current was moving through my body , Heart pounding, Heart aching, Heart beating very very fast, Muscle spasm all over my body, Burning sensation in lower legs, and sometime all over my body, pain in ankle area,.
Received first COVID shot on 3/19/21.  On 3/20/21 presenting to ER  with weakness, achiness, fever, shortness of breath after having coronavirus vaccination yesterday.  Patient is sure she had coronavirus back in November.  Received the vaccination yesterday about 11 am.  Within a couple hours she developed severe myalgias, low-grade fever.  Reports she feels a little short of breath from a myalgias.  No history of DVT or PE, urinary complaints.  Patient has syncopal episode while in triage.  No seizure activity.  Felt lightheaded with standing.  Clinical Impression: 1. Syncope  2. Vaccination reaction, initial encounter  Presentation consistent with orthostatic, vasovagal episode from recent vaccination.  Patient coronavirus previously stimulating a stronger immune response.  doubt infection, PE, worrisome arrthymia. Advised against second vaccination.  return if any problems, worsening
Soreness/swollen lymph node under left arm pit the morning after injection along with swollen arm at injection site. Soreness/swollen lymph node is still there 1 week later and has not gone down.; Swollen arm at injection site; Soreness/swollen lymph node under left arm pit; This is a spontaneous report from a contactable consumer (patient). A 40-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EP7534), via an unspecified route of administration in the left arm on 23Mar2021 at 10:30 (at the age of 40-years-old) as a single dose for COVID-19 immunization. The patient medical history included asthma. The patient had allergies to medications, food, or other products which included, shellfish, penicillin, biaxin, ceclor, sulfa, Cephalosporins. Patient reported that she took concomitant medications in two weeks as Mirabegron (MYRBETRIQ). The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021 at 07:00 patient experienced Soreness/swollen lymph node under left arm pit in the morning after the vaccination along with swollen arm at injection site. Patient stated that the Soreness/swollen lymph node is still there 1 week later and has not gone down. The patient not had covid prior vaccination; not tested covid post vaccination. The patient did not receive any treatment for the events. The outcome of events were not recovered.  No follow-up attempts are possible. No further information is expected.
8 days after shot, the injection area became red, swollen, itchy, and warm.
Information has been received from a registered nurse concerning a 5 month old female who female who on 14-MAR-2008 and 31-MAR-2008 was vaccinated po with the first and second doses of ROTATEQ. No adverse event was reported. Additional information has been requested.
Delayed hypersensitivity reaction: erythematous rash of left deltoid/injection site starting on day 8 (4/15/21)
About 36 hr after injection, felt feverish, myalgias, headache.  Had exam 12/6/07.  Red, blanching macular rash & facial/periorbital swelling started 12/9/07 & hives.
ITCHING IN RIGHT ARM, NOTICE TONGUE, CHANGES IN SWALLOWING. FEELING WARM AND HOT AND COOL
This spontaneous report as received from an unidentified nurse via a field representative refers to 2 unspecified patients of unknown ages and genders. On unknown dates, the patient were vaccinated with doses of GARDASIL (lot#, route and dose not reported). The nurse mentioned 2 patients fainted after administration of GARDASIL on unspecified dates. The patients sought medical attention in office. No treatment was given for adverse event. Both patients recovered on unspecified dates. Additional information is not expected.
Swelling and pain in left arm pit. Swelling left rib area Swelling below left breast
This spontaneous report as received from a physician refers to several patients of unknown age. The patients were vaccinated with VARIVAX (Merck) (Lot#, dose and route not reported) instead of ZOSTAVAX for shingles. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. It was not known if the patients sought for medical attention. Follow-up information has been received from the physician via a telephone memo on 10-AUG-2012 concerning that 12 patients were administered VARIVAX (Merck) instead of ZOSTAVAX. The physician did not want to provide any patient identifiers, but stated 3 patients had already been back to the clinic and vaccinated with ZOSTAVAX. And this is one of the 3 patients. No further information is available. This is one of several reports received from the same source. Additional information is not expected.
This case was reported by a lawyer and described the occurrence of chronic inflammatory demyelinating polyneuropathy in an adult female subject who was vaccinated with LYMERIX, (GlaxoSmithKline).  A physician or other health care professional has not verified this report.  The following information was received via a legal complaint.  The subject had first and second dose of LYMERIX, (GlaxoSmithKline) on 22 April 1999 and on 17 May 1999.  On 15 November 2007, 8 years after vaccination with LYMERIX, the subject experienced post-Lyme vaccination syndrome and chronic inflammatory demyelinating polyneuropathy.  The complaint alleged that the subject "sustained severe and permanent personal injuries" that were "serious, progressive, permanent, and incurable" in addition to "conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment, and injury".  This case was assessed as medically serious by GSK.  At the time of reporting the outcome of the events was unspecified.
Patient had hot, red face from nose upward. Half dollar size rxn at injection site. Went to ER. Was given steroid shot, BENADRYL q 6 hours, also dose pack for future rx fill.
Eye pain; Purplish bad rash all over the body; Exhausted; Headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (Eye pain), RASH (Purplish bad rash all over the body), HEADACHE (Headache) and FATIGUE (Exhausted) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced HEADACHE (Headache). On 07-Mar-2021, the patient experienced EYE PAIN (Eye pain), RASH (Purplish bad rash all over the body) and FATIGUE (Exhausted). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, EYE PAIN (Eye pain), RASH (Purplish bad rash all over the body), HEADACHE (Headache) and FATIGUE (Exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Short of breath. Chest pain, body ache resulting heart attack  Cad of native artery
2PM pt began w/redness of ears, mouth, nose, upper legs & arms & was scratching @ same 30 min; later swelling of upper lip & nose; parents took pt to ER was irritable & crying @ this time; rash was flattening & becoming blotchy;
Call from pt x 1 wk after flu vaccine administered. C/O significant bruising at inj site. No pain, swelling, heat at site.  Denies fever.
Information has been received from a registered nurse referring to multiple unspecified patients. On unspecified dates the patients were vaccinated with PNEUMOVAX 23 (lot # L011531, 07-JAN-2017), which was improperly stored at -0.7 centigrade degree for 5 hours (1 cycle). Previous excursion included 0.7 centigrade degree for 15 hours and -0.7 centigrade degree for 15 hours (cycling unknown). Data logger was involved. No adverse effects reported. Additional information has been requested.